At this concentration, the combination of Ad-VT and paclitaxel had a good synergistic effect, and the inhibition rate of paclitaxel on tumor cells was ~10%, and the inhibition rate of Ad-VT on tumor cells was ~40%. The gene discussed is UBN1; the disease is neoplasm.